Bristol Myers Squibb
Venture Capital
Global biopharmaceutical company that invests in early-stage biotech through partnerships, incubators, and direct investments.
Seed
Early Stage
Growth
Late Stage
Pre-Seed
Biotech
Healthcare
Oncology
biotechnology
cell therapy
immunology
Immunology
Digital Health
Medtech
- Headquarters
- Princeton, United States
- Website
- bms.com
- Total Investments
- 25
- Last Investment
- Jul 2025
- Geographic Focus
- United States, Europe, Global
Investment Thesis
Accelerate scientific breakthroughs by supporting life sciences startups and biotech entrepreneurs transforming patients’ lives through innovative science.
Investment History
Sign up to view investment history
Create a free account to see deal history, investment amounts, and round details.
Create Free Account